Search results
Links and resources related to cervical screening, management, and colposcopy guidelines and recommendations. USPSTF Screening Guidelines. ASCCP endorses the United States Preventative Services Task Force (USPSTF) cervical cancer screening guidelines. View Guidelines.
- Management Guidelines - ASCCP
The ASCCP Risk-Based Management Consensus Guidelines...
- Guidelines - ASCCP
Screening Guidelines. Screening recommendations for the...
- Management Guidelines - ASCCP
Screening Guidelines. Screening recommendations for the identification of precursors and prevention of cervical cancer. View Screening Guidelines. Management Guidelines & the Enduring Guidelines Process. Risk-based Management Guidelines for the abnormal screening results, including post-colposcopy or post-treatment scenarios.
The ASCCP Risk-Based Management Consensus Guidelines represented a consensus of 19 professional organizations and patient advocates, convened by ASCCP; they are designed to safely triage individuals with abnormal cervical cancer screening results.
ACOG joins ASCCP and SGO in endorsing the USPSTF recommendations for cervical cancer screening in average-risk individuals aged 30–65 years. The guidelines include primary hrHPV testing, cytology alone, and co-testing as options, and recommend screening initiation at age 21 years.
The Enduring Guidelines are a process to update the 2019 ASCCP Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. They provide risk estimates and clinical action thresholds for different combinations of screening results and new tests.
1 paź 2021 · The 2019 American Society for Colposcopy and Cervical Pathology (ASCCP) risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors, published in April 2020, 1 represent a shift away from results-based management and toward risk-based management.
The new guidelines follow a risk-based approach to determine the need for surveillance, colposcopy, or treatment based on current and past test results. They also provide recommendations for HPV testing, expedited treatment, and surveillance intervals after treatment.
